Veeva Systems Inc. (VEEV) - Stock Analysis

Last updated: Aug 17, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Revenue recently grew 16%, prior results exceeded guidance, and platform expansion plus major customer commitments support growth. Shares gained 35.3% through August 19, with fiscal Q2 earnings scheduled for August 26.

Loading chart data...

Idea window: 8/19/2026 – 8/26/2026Sector: Healthcare

AI Analyst Overview

Last Price
$251.00
Market Cap
$40.77B
1D Return
+3.40%
YTD Return
+12.44%

Loading chart data...

Valuation Metrics

P/E
43.6
P/B
5.6
P/S
12.3
EV/EBITDA
31.4
Div Yield
—

Fundamental Analysis

9.0

Key Financial Insights: • High Margins • Strong Cash Flow • Premium Valuation VEEV remains fundamentally strong with durable high margins, strong cash flow, and a fortress balance sheet, but its premium valuation and heavy stock-based compensation limit upside.

StrongCashFlow
PremiumValuation

Price Behavior

6.0

Key Price Behavior Insights: • Strong Uptrend • Breakout Support • Overbought Pullback Support Level: $230-$235 Resistance Level: $252.64 VEEV has surged in the last month with a strong higher-highs/higher-lows uptrend, but it looks extended near $252.64 so $230-$235 is the key support to hold for a healthy consolidation.

bullish
overbought

Sentiment & News

7.0

Key News Insights: • Strong Fundamentals • CRM Momentum • Choppy Trading Veeva remains a fundamentally solid but volatile laggard, with attractive valuation, improving profitability and a key Eli Lilly CRM win offset by AI and execution concerns.

Veeva
Volatility
AI

AI Summary

7.0
Positive

Veeva remains a high-quality, cash-rich platform with strong product momentum and customer wins, but at ~33x earnings the stock now hinges on proving that AI, Vault CRM migrations, and product expansion can sustain mid-teens growth without any execution slip that would trigger multiple compression.

Quality
Valuation
Execution
AI summary updated 2 days ago

Description

Veeva Systems develops cloud software and data solutions for companies in the life sciences sector across North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. Its product portfolio includes a commercial suite for sales, marketing and customer engagement, data and analytics offerings, and Veeva Vault, a platform for enterprise content and data management across commercial and R&D functions such as clinical, regulatory, quality, and safety. The firm also provides implementation, integration, training and managed services; it was incorporated in 2007, renamed Veeva Systems in 2009, and is headquartered in Pleasanton, California.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Aug 19Aug 26VEEVVeeva Systems Inc.
Revenue recently grew 16%, prior results exceeded guidance, and platform expansion plus major customer commitments support growth. Shares gained 35.3% through August 19, with fiscal Q2 earnings scheduled for August 26.
Active+0.0%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.